Indications for: INFED
Iron deficiency where oral therapy is intolerable or unsatisfactory response.
Adults and Children:
<4mos: not recommended. Give by IV or deep IM inj into upper outer quadrant of buttock only. Administer 0.5mL test dose first; if no signs/symptoms of anaphylactic-type reactions, may give full therapeutic dose. ≥4mos: Iron deficiency anemia: determine total dose based on hemoglobin and body weight (see full labeling). Iron replacement for blood loss: Replacement iron (in mg) = blood loss (in mL) × hematocrit. See full labeling.
Risk for anaphylactic-type reactions.
Monitor for anaphylactic-type reactions, esp. in patients with history of drug allergies, asthma; have epinephrine available. Avoid large IV doses; higher incidence of adverse events. Severe hepatic impairment. Avoid during acute phase of infectious kidney disease. Dialysis. Cardiovascular disease. Rheumatoid arthritis. Iron overload. Neonates. Pregnancy. Nursing mothers.
Concomitant ACE inhibitors may increase the risk for anaphylactic-type reactions. May falsely elevate serum bilirubin or decrease serum calcium levels.
Nausea, vomiting, chest pain, backache, hypersensitivity, dyspnea, hypotension, pruritus, flushing, dizziness; anaphylactic reactions (may be fatal; even if test dose was tolerated), cardiovascular events, inj site reactions, others; possible sepsis in neonates.
Generic Drug Availability: